Vistagen Therapeutics CEO Shawn Singh's 2020 pay slips 2% to $934K

Vistagen Therapeutics reports 2020 executive compensation

By ExecPay News

Published: July 27, 2020

Vistagen Therapeutics reported fiscal year 2020 executive compensation information on July 27, 2020.
In 2020, five executives at Vistagen Therapeutics received on average a compensation package of $656K, which is about the same as previous year.
Average pay of disclosed executives at Vistagen Therapeutics
Shawn K. Singh, Chief Executive Officer, received $934K in total, which decreased by 2% compared to 2019. 53% of Singh's compensation, or $498K, was in salary. Singh also received $436K in option awards.
H. Ralph Snodgrass, Chief Scientific Officer, received a compensation package of $671K, which increased by 5% compared to previous year. 62% of the compensation package, or $417K, was in salary.
Jerrold D. Dotson, Chief Financial Officer, earned $597K in 2020, a 10% increase compared to previous year.
Mark A. Smith, Chief Medical Officer, received $597K in 2020, which decreases by 4% compared to 2019.
Mark A. McPartland, Vice President, Corporate Development, earned $480K in 2020, a 5% decrease compared to previous year.
Vistagen Therapeutics' fiscal year ends on March 31.

Related executives

Shawn Singh

Vistagen Therapeutics

Chief Executive Officer

H Snodgrass

Vistagen Therapeutics

Chief Scientific Officer

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

Mark McPartland

Vistagen Therapeutics

Vice President, Corporate Development

You may also like

Source: SEC filing on July 27, 2020.